News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,246 Results
Type
Article (21810)
Company Profile (58)
Press Release (274375)
Multimedia
Podcasts (56)
Webinars (9)
Section
Business (82995)
Career Advice (389)
Deals (12331)
Drug Delivery (83)
Drug Development (27249)
Employer Resources (62)
FDA (8470)
Job Trends (7918)
News (126935)
Policy (17283)
Tag
2025 Best Places to Work (12)
2026 Best Places to Work (15)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Biotech Bay Standard (2)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (1895)
Academic (2)
Accelerated approval (40)
ADA (30)
Adcomms (18)
Allergies (98)
Alliances (21792)
ALS (101)
Alzheimer's disease (996)
Antibody-drug conjugate (ADC) (188)
Approvals (8996)
Artificial intelligence (460)
ASCO (94)
Autoimmune disease (153)
Automation (33)
Bankruptcy (110)
Belgium (15)
Best Places to Work (7228)
BIO (28)
Biologics (43)
BIOSECURE Act (4)
Biosimilars (150)
BioSpace Insights (61)
Biotechnology (27)
Bispecific (24)
Bladder cancer (105)
Brain cancer (38)
Breast cancer (382)
Cancer (2797)
Cardiovascular disease (339)
Career advice (375)
Career pathing (17)
CAR-T (95)
CDC (73)
CDMO (55)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (321)
Cervical cancer (48)
Clinical research (24882)
Collaboration (1233)
Commercialization (38)
Company closure (2)
Compensation (172)
Complete response letters (31)
COVID-19 (2078)
CRISPR (60)
CRO (4)
C-suite (627)
Cystic fibrosis (65)
Data (4688)
Decentralized trials (3)
Denatured (14)
Depression (155)
Dermatology (123)
Diabetes (427)
Diagnostics (4356)
Digital health (79)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (165)
Drug pricing (151)
Drug shortages (13)
Duchenne muscular dystrophy (133)
Earnings (25429)
Editorial (45)
Employer branding (8)
Employer resources (59)
ESMO (128)
Events (42980)
Executive appointments (597)
Eye disease (8)
FDA (10895)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (16)
Frontotemporal dementia (17)
Funding (1117)
Gene editing (103)
Generative AI (34)
Gene therapy (245)
GLP-1 (567)
Government (4222)
Grass and pollen (5)
Guidances (226)
Healthcare (11995)
Hematology (85)
HIV (92)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (61)
Immunology and inflammation (62)
Immuno-oncology (48)
Indications (143)
Infectious disease (2401)
Inflammatory bowel disease (118)
Inflation Reduction Act (10)
Influenza (126)
Intellectual property (113)
Interviews (38)
IPO (5297)
IRA (31)
Job creations (981)
Job search strategy (321)
JPM (14)
Kidney cancer (9)
Kidney disease (89)
Labor market (43)
Layoffs (159)
Leadership (15)
Legal (3107)
Licensing (68)
Liver cancer (41)
Longevity (40)
Lung cancer (389)
Lung diease (13)
Lymphoma (206)
Machine learning (21)
Management (23)
Manufacturing (504)
Marketing (23)
MASH (109)
Medical affairs (3)
Medical device (6444)
Medtech (6593)
Melanoma (59)
Mergers & acquisitions (7675)
Metabolic disorders (980)
Middle East (1)
mRNA (135)
Multiple sclerosis (78)
Multispecific (1)
NASH (8)
Netherlands (14)
Neurodegenerative disease (224)
Neuropsychiatric disorders (64)
Neuroscience (1909)
Neurotech (1)
NextGen: Class of 2026 (3887)
Non-profit (3650)
Now hiring (15)
Obesity (432)
Opinion (138)
Ovarian cancer (79)
Pain (143)
Pancreatic cancer (140)
Parkinson's disease (177)
Partnered (17)
Patents (237)
Patient advocacy (4)
Patient recruitment (368)
Patient selection (42)
Peanut (32)
People (25301)
Peptides (21)
Pharmaceutical (20)
Pharmacy benefit managers (36)
Phase 1 (6135)
Phase 2 (9940)
Phase 3 (10155)
Pipeline (6386)
Policy (259)
Postmarket research (1321)
Preclinical (2433)
Press Release (20)
Prostate cancer (186)
Psychedelics (60)
Radioligand (1)
Radiopharmaceuticals (122)
Rare diseases (603)
Real estate (2079)
Recruiting (22)
Regenerative medicine (8)
Regulatory (13630)
Reports (30)
Research institute (1766)
Resumes & cover letters (27)
Rett syndrome (5)
RNA editing (7)
RSV (67)
Saudi Arabia (1)
Schizophrenia (120)
Series A (163)
Series B (117)
Service/supplier (3)
Sickle cell disease (83)
Special edition (13)
Spinal muscular atrophy (76)
Sponsored (21)
Startups (1458)
Stem cells (4)
Stomach cancer (2)
Substance use disorders (19)
Supply chain (71)
Switzerland (9)
Tariffs (42)
Tax incentives (1)
The Weekly (41)
Vaccines (942)
Venture capital (56)
Weight loss (280)
Wet AMD (3)
Women's health (173)
Worklife (8)
Date
Last 7 days (254)
Last 30 days (1301)
Last 365 days (12493)
2026 (11614)
2025 (12210)
2024 (14538)
2023 (16244)
2022 (22383)
2021 (25752)
2020 (27694)
2019 (25270)
2018 (19040)
2017 (12694)
2016 (13342)
2015 (14513)
2014 (10762)
2013 (8284)
2012 (8717)
2011 (9210)
2010 (7957)
Location
Africa (456)
Alabama (27)
Alaska (5)
Arizona (224)
Arkansas (12)
Asia (15545)
Australia (3009)
California (5545)
Canada (2490)
China (639)
Colorado (302)
Connecticut (366)
Delaware (177)
Europe (34919)
Florida (950)
Georgia (262)
Hawaii (3)
Idaho (33)
Illinois (758)
India (89)
Indiana (532)
Iowa (20)
Japan (423)
Kansas (83)
Kentucky (43)
Louisiana (51)
Maine (89)
Maryland (949)
Massachusetts (3884)
Michigan (184)
Minnesota (339)
Mississippi (3)
Missouri (112)
Montana (12)
Nebraska (18)
Nevada (109)
New Hampshire (53)
New Jersey (2183)
New Mexico (12)
New York (2027)
North Carolina (970)
North Dakota (5)
Northern California (2900)
Ohio (220)
Oklahoma (15)
Oregon (22)
Pennsylvania (1355)
Puerto Rico (11)
Rhode Island (25)
South America (519)
South Carolina (28)
South Dakota (2)
Southern California (2197)
Tennessee (150)
Texas (1053)
United States (23454)
Utah (324)
Virginia (167)
Washington D.C. (44)
Washington State (610)
West Virginia (3)
Wisconsin (83)
Wyoming (3)
296,246 Results for "bellus health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
GSK culls cough program for drug at the heart of $2B Bellus bet after Phase 3 fail
Camlipixant, which GSK picked up in its $2 billion buyout of Bellus Health in April 2023, “is unlikely to transform patient care,” the pharma said.
July 17, 2026
·
1 min read
·
Tristan Manalac
Press Releases
TempraMed Announces VIVI Cap Smart Connectivity with Apple Health and Google Fit, Providing Better Health Outcomes and Data Tracking
VIVI Cap Smart transforms injectable medication protection into a connected health-data layer, enabling patients, caregivers and digital-health platforms to capture medication-use, temperature and adherence signals.
October 5, 2026
·
8 min read
BELLUS Health Announces Meeting Updates
BELLUS Health Inc. has announced the meeting and record dates for the special meeting of shareholders to be held in connection with the acquisition of the Company by GSK plc for US$2.0 billion pursuant to a plan of arrangement.
April 26, 2023
·
3 min read
Business
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
BELLUS Health Inc. reported its financial and operating results for the quarter ended March 31, 2023.
May 12, 2023
·
13 min read
BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference
BELLUS Health Inc. today announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will participate in the Respiratory/Infections panel discussion at the Cowen 43rd Annual Health Care Conference, being held March 6 - 8, 2023 in Boston, MA.
March 1, 2023
·
6 min read
Deals
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
BELLUS Health Inc. announced that the Superior Court of Québec has issued an interim order authorizing, among other things, the holding of a special meeting of shareholders of BELLUS on June 16, 2023.
May 16, 2023
·
7 min read
BELLUS Health to Participate in Two Upcoming November 2022 Healthcare Investor Conferences
BELLUS Health Inc. announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will be participating in two upcoming healthcare investor conferences.
November 10, 2022
·
5 min read
Business
BELLUS Health Reports Year 2022 Financial Results and Business Highlights
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough, starting with the development of camlipixant (BLU-5937) for the treatment of refractory chronic cough (“RCC”), today reported its financial and operating results for the year ended December 31, 2022.
March 21, 2023
·
12 min read
Press Releases
AmacaThera and Merck Animal Health Announce Collaboration in Animal Health
November 2, 2026
·
4 min read
Business
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), today reported its financial and operating results for the second quarter ending June 30, 2022.
August 10, 2022
·
12 min read
1 of 29,625
Next